Navigation Links
Standard Management Announces OTCBB Listing
Date:9/6/2007

INDIANAPOLIS, Sept. 6 /PRNewswire-FirstCall/ -- Standard Management Corporation ("Standard Management" or the "Company") (OTC Bulletin Board: SMAN), an Indianapolis-based company, provides through Universal Healthcare Company, LLC ("Universal" or "UHCC") pharmaceuticals to the long-term care and infusion therapy sector of the healthcare industry.

(http://www.newscom.com/cgi-bin/prnh/20010416/STANDARDLOGO )

Martial Knieser, Executive Vice President, Corporate Development stated, "This listing to the OTCBB is the next step in returning to the Nasdaq Exchange."

The Company voluntarily delisted from Nasdaq on May 18, 2006 in order to transition the Company from financial services to healthcare with less restrictions in pursuing acquisitions.

The common stock of Standard Management was previously listed on the pink sheets as SMANPK.

Mark Long, President of Universal commented, "With our acquisition pipeline, management believes the Company can reach its goal of approximately $100 million of run rate revenue by year end 2007.

This press release contains "forward-looking statements" within the meaning of section 27 A of the Securities Act of 1933. The use of the words "believe," "expect," "anticipate," "intend," "may," estimate," "could," "plans," and other similar expressions, or the negations thereof, generally identify forward-looking statements. Forward-looking statements in this press release include, without limitation, the ability of the Company to address the factors sighted by our independent auditors as a basis for their qualified audit opinion, the performance and growth of our business, potential future acquisitions, and their impact on the Company's performance. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors, which could cause actual results to be materially different from those contemplated by the forward-looking statements. Such factors include, but are not limited to the ability of our management team to successfully operate a health services business with limited experience in that industry; our ability to expand our health services business both organically and through acquisitions, including our ability to identify suitable acquisition candidates, acquire them at favorable prices and successfully integrate them into our business; general economic conditions and other factors, including prevailing interest rate levels and stock market performance, which may affect our ability to obtain the proposed capital and additional capital when needed and on favorable terms; customer response to new products, distribution channels and marketing initiatives; and increasing competition in the sale of our products.

We caution you that, while forward-looking statements reflect our good faith beliefs, these statements are not guarantees of future performance. In addition, we disclaim any obligation to publicly update or revise any forward- looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Standard Management is a holding company headquartered in Indianapolis, IN. Information about the Company can be obtained by calling the Investor Relations Department at 317.574.6224 or via the Internet at http://www.SMAN.com.


'/>"/>
SOURCE Standard Management Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New standards for Human Research Safety
2. Angioplasty Should be the Standard
3. Presence of substandard drugs can pose concern for patients
4. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
5. Researchers Feel The Need For Standards Of Practice In Immunoglobulin Therapy
6. Chinese Poultry Vaccine Could Be Sub-Standard: Expert
7. DMAA to Develop Disease Management Standards by December
8. Setting Standards: Benchmark Medical Tests to Gauge Accuracy of Medical Tests
9. Medical Colleges, Confident of Meeting Standards Before 90-days deadline
10. Cancer Care To Be Standardized
11. An International Growth Standard For Childs Releases By WHO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... of $3,296 in property taxes a year. In some states—like New York, New ... , By contrast, many overseas retirement havens have extremely low property-tax rates, which ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: